"I am looking forward to Rupert joining our R&D team. He brings strong leadership and broad expertise in all stages of Clinical Development. His impressive track record in successful drug development, in particular his experience in neuroimmunology and rare diseases, matched with our strong neuroscience dedicated clinical development organization, will enable us to further advance on our prioritized biology areas and to deliver innovative and life-changing therapies," says
"Lundbeck is a recognized premier neuroscience company with a long history and reputation for innovation. I'm thrilled to have the opportunity to be a part of Lundbeck's R&D team and to continue the work to provide breakthrough treatments for people with brain diseases," says
Contacts
Investors: | Media: |
Vice President, Investor Relations | Media Relations Lead, Corp. Communication |
PALO@lundbeck.com | THMR@lundbeck.com |
+45 30 83 24 26 | +45 30 83 30 24 |
About
Too many people worldwide live with brain diseases - complex conditions often invisible to others that nonetheless take a tremendous toll on individuals, families and societies. We are committed to fighting stigma and discrimination against people living with brain diseases and advocating for broader social acceptance of people with brain health conditions. Every day, we strive for improved treatment and a better life for people living with brain disease.
We have approximately 5,600 employees in more than 50 countries, and our products are available in more than 100 countries. Our research programs tackle some of the most complex challenges in neuroscience, and our pipeline is focused on bringing forward transformative treatments for brain diseases for which there are few, if any therapeutic options. We have research facilities in
For additional information, we encourage you to visit our corporate site www.lundbeck.com, and connect with us on Twitter at @Lundbeck and via LinkedIn. For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us on Twitter at @Lundbeck and via LinkedIn.
Ottiliavej 9, 2500 Valby,
+45 3630 1311
info@lundbeck.com
https://news.cision.com/h--lundbeck-a-s/r/lundbeck-appoints-dr--rupert-sandbrink-as-head-of-clinical-development,c3475452
https://mb.cision.com/Main/18215/3475452/1513278.pdf
(c) 2021 Cision. All rights reserved., source